Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.

Item

http://www.wikidata.org/entity/Q35886086

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.

@ast

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.

@en

type

Item

label

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.

@ast

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.

@en

prefLabel

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.

@ast

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.

@en

P1476

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.

@en

P2093

Keiichi Fujiwara

http://www.w3.org/2001/XMLSchema#string

P2860

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study.

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer.

Principles and practice of intraperitoneal chemotherapy for ovarian cancer.

Can carboplatin replace cisplatin for intraperitoneal use?

Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up.

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

P304

75-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3802/JGO.2012.23.2.75

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224812107

http://www.w3.org/2001/XMLSchema#string

P698

22523620

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

chemotherapy

P932

3325351

http://www.w3.org/2001/XMLSchema#string